Hospital Clinico Universitario De Valladolid — Clinical Trial Site

113 Registered trials

42 Currently recruiting

Organisation

Hospital Clinico Universitario De Valladolid

Location

Valladolid, Spain

Identifier

ORG-100043716

Address

Avenida Ramon Y Cajal 3, 47003, Spain

Departments

#2323:servicio de neurología
#724002:Neurología
1213:Oncología Médica
3142: endocrinología y nutrición
7017: Oncología
Anaesthesiology
Cardiología
Cardiology
Cardiovascular surgery
Departamento de Neurología
Department of Neurology
Digestive
Digestive service
Endocrinología y Nutrición
Endocrinology
Endocrinology and nutrition
Gastroenterology
Hematology Service
Hepatology
Infectious Diseases
Interventional Cardiology
Medica Oncology
Medical oncology
Microbiología e Inmunología
N/A
NA
Nephrology
Neurología
Neurology
Neurology Department
Oftalmología
Oncology
Oncology Service
Ophthalmology
Ophthalmology service
ORL
Orthopaedic Surgery and Traumatology
Orthopedic and Traumatology surgery
Pediatric oncology and hematology department
Preventive Medicine
Preventive medicine and public health service
Radiation Oncology
Servicio de digestivo
Servicio de Digestivo
Servicio de Hematologia; ext 86331
Servicio de Neurología
Servicio de Neurologia Unidad de Ictus
Servicio de Oncologia
Servicio de Oncología y Hematología Pediátricas
Servicio Medicina Intensiva
Stroke Unit
Urology

Clinical trials at this site (113)

Search interface

A Study to Evaluate the Efficacy, Safety, and Tolerability of Atogepant for the Preventive Treatment of Menstrual Migraine Ended

2024-512946-41-00 Menstrual Migraine 5 2025-03-05
An open label, single-arm, phase 2 study of perioperative sacituzumab govitecan in combination with zimberelimab and domvanalimab for patien… Ended

2023-504420-26-00 Bladder Cancer 4 2025-01-13
REIMAGINE 5: A research study to see how much CagriSema (1.0 mg once weekly) lowers blood sugar and body weight compared to tirzepatide (5 m… Ended

2023-509600-15-00 Type 2 Diabetes 5 2024-10-18
LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis Ended

2024-512676-36-00 Langerhans Cell Histiocytosis 10 2024-10-09
A Phase 2a Study of Efinopegdutide in Adults With Compensated Cirrhosis Secondary to Metabolic Dysfunction-Associated Steatohepatitis Ended

2024-510923-20-00 Metabolic Dysfunction-Associated Steatohepatitis 4 2024-09-16
ARTEMIS - A research study to look at how ziltivekimab works compared to placebo in people who have had a heart attack Ended

2023-506876-28-00 The medical condition we are investigating is type 1 AM 5 2024-08-01
A Study Evaluating Pharmacokinetic similarity between ABP 234 and Keytruda® (pembrolizumab) in Subjects with Early-stage Non-squamous Non-sm… Ended

2023-508359-38-00 Early-stage Non-squamous Non-small Cell Lung Cancer 5 2024-06-05
Randomized, Double-Blind, Placebo-Controlled, Multiple-Attack Study with an Open-Label Extension to Evaluate the Efficacy, Safety, Tolerabil… Ended

2023-506029-12-00 Migraine 5 2024-04-03
A Phase 2, open-label, multi-centre, multi-national interventional trial to evaluate the efficacy and safety of erdafitinib (ERDA) monothera… Ended

2024-512573-27-01 Muscle-invasive bladder cancer (MIBC) 4 2023-12-11
A Phase 3 Study of Front‑line Platinum Doublet Therapy With Sotorasib Versus Pembrolizumab in PD-L1 Negative KRAS p.G12C Positive Advanced/M… Ended

2022-501863-41-00 Subjects With Stage IV or Advanced Stage IIIB/C Nonsqua 5 2023-11-13
A clinical study to assess how safe and effective it is for subjects with hepatocellular carcinoma (HCC) to receive radiation therapy with T… Ended

2023-508945-41-00 Hepatocellular Carcinoma 4 2023-10-11
Study to evaluate reduced antiplatelet therapy after angiolite stent implantation in patients with coronary artery disease Ended

2023-507015-35-00 Coronary Artery Disease 5 2023-10-06
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-1) Ended

2022-502839-19-00 Obesity 5 2023-09-14
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended

2022-501176-26-00 Acute Ischemic Stroke and High-Risk Transient Ischemic 5 2023-08-04
A Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis Ended

2024-510627-20-00 Non-alcoholic Steatohepatitis (NASH) Cirrhosis 5 2023-07-28
Study of chemotherapy and immunotherapy before and after surgery in patients with non-small cell lung cancer whose tumor is located in the u… Ended

2024-512359-19-00 Resectable Non-small cell lung cancer Pancoast tumor 4 2023-05-12
ETOP 18-21 AMAZE-lung: A clinical study exploring the effect of amivantamab and lazertinib plus bevacizumab treatment, in people diagnosed w… Ended

2024-512288-29-00 Patients with EGFR-mutant (L858R or del19 only) advance 4 2023-04-11
Phase II study to evaluate diarrhoea discontinuations at 3 cycles in patients with early-stage HER2 positive, hormone receptor positive brea… Ended

2024-514630-21-00 HER2 positive (HER2+), Hormone Receptor positive (HR+) 4 2022-08-11
Efficacy and safety of remibrutinib compared to teriflunomide in participants with relapsing multiple sclerosis, followed by long term treat… Ended

2023-509345-12-00 Multiple Sclerosis 5 2022-06-22
A research study to find out whether a medicine called inclisiran helps to prevent cardiovascular death, heart attacks or strokes in people … Ended

2024-510735-21-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2021-11-26
Study of Nivolumab and Ipilimumab plus chemotherapy as a treatment for patients with stage IV lung cancer with brain metastases. Ended

2024-513866-20-00 Non-small cell lung cancer with brain metastasis 4 2021-11-18
Randomized clinical trial assessing the value of Beta-Blockers and Antiplatelet Agents in patients with Spontaneous Coronary Artery Dissecti… Ended

2024-516039-28-00 Spontaneous Coronary Artery Dissection. 6 2021-09-28
Phase III, multicentre, randomized, open clinical trial comparing treatment with allogenic mesenchymal cells against autologous mesenchymal … Ended

2024-514545-11-00 Knee osteoarthritis 5 2021-05-26
Research study on whether semaglutide works in people with non-alcoholic steatohepatitis (NASH) Ended

2023-506962-30-00 Non-alcoholic steatohepatitis (NASH) 5 2021-03-29